Phreesia, Inc. (NYSE:PHR – Get Rating) has earned a consensus rating of “Buy” from the sixteen analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have covered […]
Phreesia, Inc. (NYSE:PHR – Get Rating) has earned a consensus rating of “Buy” from the sixteen analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have covered […]
Phreesia (NYSE:PHR – Get Rating) and Enjoy Technology (NASDAQ:ENJY – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Profitability This table compares Phreesia and Enjoy Technology’s net margins, […]
Phreesia (NYSE:PHR – Get Rating) had its price objective decreased by analysts at Royal Bank of Canada from $29.00 to $20.00 in a research report issued to clients and investors on Monday, The Fly reports. Royal Bank of Canada’s price target would indicate a potential downside of 3.33% from the stock’s current price. A number […]
Phreesia (NYSE:PHR – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “Phreesia Inc. provides a patient intake management platform. The company’s SaaS platform engages patients in their care and provides a modern, consistent […]